Search research articles
Contact Us
Filters
Showing results (51-60 of 180) with videos related to
Page
of 18
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 12, 2016
Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains
Gina Song, Oscar T Suzuki, Charlene M Santos, et al.
American Journal of Medical Genetics. Part A
|
February 24, 2007
Trisomy 18: Fetal ultrasound findings at different gestational ages
E Viora, C Zamboni, G Mortara, et al.
Cancer Chemotherapy and Pharmacology
|
April 20, 2005
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies
James A Posey, Hui Wang, Joelle Hamilton, et al.
Cancer Chemotherapy and Pharmacology
|
October 25, 2007
Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts
William C Zamboni, Sandra Strychor, Erin Joseph, et al.
Science Advances
|
August 25, 2020
A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
Lauren S L Price, Stephan T Stern, Allison M Deal, et al.
Acta Biomaterialia
|
April 29, 2008
LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas
Wesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 6, 2005
Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenografts
John M Harrold, Julie L Eiseman, Erin Joseph, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
December 18, 2015
Development and evaluation of a novel product to remove surface contamination of hazardous drugs
Joshua Cox, Vonni Speed, Sara O'Neal, et al.
Acta Biomaterialia
|
April 29, 2008
Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles
Wesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Journal of Geriatric Oncology
|
August 27, 2022
Chemotherapy dosing in older adults with cancer: One size does NOT fit all
Grant R Williams, Darryl Outlaw, R Donald Harvey, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 180) with videos related to
Sort By:
Page
of 18
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 12, 2016
Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains
Gina Song, Oscar T Suzuki, Charlene M Santos, et al.
American Journal of Medical Genetics. Part A
|
February 24, 2007
Trisomy 18: Fetal ultrasound findings at different gestational ages
E Viora, C Zamboni, G Mortara, et al.
Cancer Chemotherapy and Pharmacology
|
April 20, 2005
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies
James A Posey, Hui Wang, Joelle Hamilton, et al.
Cancer Chemotherapy and Pharmacology
|
October 25, 2007
Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts
William C Zamboni, Sandra Strychor, Erin Joseph, et al.
Science Advances
|
August 25, 2020
A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
Lauren S L Price, Stephan T Stern, Allison M Deal, et al.
Acta Biomaterialia
|
April 29, 2008
LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas
Wesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 6, 2005
Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenografts
John M Harrold, Julie L Eiseman, Erin Joseph, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
December 18, 2015
Development and evaluation of a novel product to remove surface contamination of hazardous drugs
Joshua Cox, Vonni Speed, Sara O'Neal, et al.
Acta Biomaterialia
|
April 29, 2008
Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles
Wesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Journal of Geriatric Oncology
|
August 27, 2022
Chemotherapy dosing in older adults with cancer: One size does NOT fit all
Grant R Williams, Darryl Outlaw, R Donald Harvey, et al.
Page
of 18